High resolution crystal structures of Clostridium botulinum neurotoxin A3 and A4 binding domains

J Struct Biol. 2018 May;202(2):113-117. doi: 10.1016/j.jsb.2017.12.010. Epub 2017 Dec 26.

Abstract

Clostridium botulinum neurotoxins (BoNTs) cause the life-threatening condition, botulism. However, while they have the potential to cause serious harm, they are increasingly being utilised for therapeutic applications. BoNTs comprise of seven distinct serotypes termed BoNT/A through BoNT/G, with the most widely characterised being sub-serotype BoNT/A1. Each BoNT consists of three structurally distinct domains, a binding domain (HC), a translocation domain (HN), and a proteolytic domain (LC). The HC domain is responsible for the highly specific targeting of the neurotoxin to neuronal cell membranes. Here, we present two high-resolution structures of the binding domain of subtype BoNT/A3 (HC/A3) and BoNT/A4 (HC/A4) at 1.6 Å and 1.34 Å resolution, respectively. The structures of both proteins share a high degree of similarity to other known BoNT HC domains whilst containing some subtle differences, and are of benefit to research into therapeutic neurotoxins with novel characteristics.

Keywords: Binding domain structure; Botulinum neurotoxin; Clostridium botulinum; Crystallography; Subtypes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence / genetics
  • Botulinum Toxins, Type A / chemistry*
  • Botulinum Toxins, Type A / genetics
  • Botulism / genetics
  • Botulism / microbiology*
  • Clostridium botulinum / chemistry*
  • Clostridium botulinum / genetics
  • Clostridium botulinum / pathogenicity
  • Humans
  • Neurons / drug effects
  • Protein Binding
  • Protein Domains / genetics

Substances

  • Botulinum Toxins, Type A